We are live on
!
Find out more
CCM
Cupps Capital Management Portfolio holdings
AUM
$231M
1-Year Est. Return
49.73%
This Fund
S&P 500
This Quarter
Est. Return
+19.18%
1 Year Est. Return
+49.73%
3 Year Est. Return
+212.7%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
-$156M
(-40%)
Cap. Flow
-$194M
Cap. Flow
% of AUM
-83.99%
Top 10 Holdings %
Top 10 Hldgs %
24.21%
Holding
206
New
45
Increased
20
Reduced
112
Closed
29
Top Buys
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$2.5M |
| 2 |
Glaukos
GKOS
|
+$2.17M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
+$1.61M |
| 4 |
CAVM
Cavium, Inc.
CAVM
|
+$1.52M |
| 5 |
BLUE
bluebird bio
BLUE
|
+$1.51M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$9.12M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
+$8.36M |
| 3 |
Amazon
AMZN
|
+$7.51M |
| 4 |
Burlington
BURL
|
+$6.63M |
| 5 |
Texas Roadhouse
TXRH
|
+$5.36M |
Sector Composition
| 1 | Technology | 39.39% |
| 2 | Healthcare | 24.2% |
| 3 | Consumer Discretionary | 10.03% |
| 4 | Industrials | 9.46% |
| 5 | Real Estate | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Workday
WDAY
$35.8B
| $1.21M | 0.52% |
+13,175
| New | +$1.1M |
|
|
ARIA
77
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.21M | 0.52% |
+88,235
| New | +$886K |
|
78
Nutanix
NTNX
$14.9B
| $1.21M | 0.52% |
+32,570
| New | +$1.21M |
|
79
Theravance Biopharma
TBPH
$877M
| $1.2M | 0.52% |
+33,170
| New | +$924K |
|
80
Atlassian
TEAM
$23.7B
| $1.18M | 0.51% |
39,349
+21,955
| +126% | +$642K |
|
81
Ulta Beauty
ULTA
$20.6B
| $1.17M | 0.5% |
4,901
-10,647
| -68% | -$2.69M |
|
|
SCAI
82
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $1.17M | 0.5% |
23,899
-46,266
| -66% | -$2.13M |
|
83
Global Payments
GPN
$21.3B
| $1.14M | 0.49% |
14,899
-15,018
| -50% | -$1.13M |
|
84
Lexicon Pharmaceuticals
LXRX
$1.06B
| $1.13M | 0.49% |
+62,549
| New | +$1.01M |
|
85
Euronet Worldwide
EEFT
$3.1B
| $1.12M | 0.48% |
13,663
-26,427
| -66% | -$2.02M |
|
86
Builders FirstSource
BLDR
$7.99B
| $1.12M | 0.48% |
97,035
-86,870
| -47% | -$1.09M |
|
87
Arista Networks
ANET
$212B
| $1.1M | 0.48% |
207,632
+74,560
| +56% | +$355K |
|
|
IRBT
88
DELISTED
iRobot
IRBT
| $1.09M | 0.47% |
+24,815
| New | +$973K |
|
89
Fair Isaac
FICO
$29.2B
| $1.05M | 0.46% |
8,436
-9,184
| -52% | -$1.15M |
|
90
Blackbaud
BLKB
$1.49B
| $1.05M | 0.45% |
15,778
-22,167
| -58% | -$1.5M |
|
91
Shopify
SHOP
$160B
| $999K | 0.43% |
+232,850
| New | +$889K |
|
92
Dycom Industries
DY
$12.2B
| $977K | 0.42% |
11,955
-24,444
| -67% | -$2.16M |
|
93
MaxLinear
MXL
$6.43B
| $969K | 0.42% |
+47,812
| New | +$939K |
|
|
XLRN
94
DELISTED
Acceleron Pharma
XLRN
| $966K | 0.42% |
26,699
-16,548
| -38% | -$548K |
|
95
Wayfair
W
$11.8B
| $959K | 0.42% |
24,382
-9,084
| -27% | -$367K |
|
|
SGEN
96
DELISTED
Seagen Inc. Common Stock
SGEN
| $919K | 0.4% |
+17,020
| New | +$807K |
|
97
Planet Fitness
PLNT
$4.14B
| $889K | 0.38% |
44,324
-33,171
| -43% | -$683K |
|
98
Citizens Financial Group
CFG
$30.6B
| $888K | 0.38% |
35,968
+4,364
| +14% | +$100K |
|
99
Cognex
CGNX
$10.7B
| $887K | 0.38% |
+33,598
| New | +$806K |
|
|
ORBC
100
DELISTED
ORBCOMM, Inc.
ORBC
| $884K | 0.38% |
86,265
+72,350
| +520% | +$739K |
|
Similar funds
SA
WIM
EDRE
RIG
VBCP
TI
ZBI
MI
Cupps Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Cupps Capital Management held 206 positions worth $231M, down 40% from $387M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Cupps Capital Management withdrew a net $194M in Q3 2016, closing 29 positions and reducing 112 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $3.68M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cupps Capital Management opened a new position in Medidata Solutions, Inc. worth $2.63M.
- Cupps Capital Management's largest Q3 2016 buy was Medidata Solutions, Inc.: 47,254 shares worth $2.63M.
- Cupps Capital Management added most to Cavium, Inc. in Q3 2016, an estimated $1.52M increase.
- Cupps Capital Management's biggest Q3 2016 reduction was Abiomed Inc, cutting an estimated $9.12M.
- Cupps Capital Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $3.68M.
- Cupps Capital Management's ten largest holdings make up 24% of its $231M portfolio in Q3 2016.
- Cupps Capital Management opened 45 new positions and closed 29 in Q3 2016.
- Cupps Capital Management's portfolio value fell 40% quarter-over-quarter to $231M.
Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.